Baoshan Cao Selected Research

Opioid Analgesics (Opioids)

1/2022

Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross-sectional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baoshan Cao Research Topics

Disease

13	Neoplasms (Cancer) 01/2024 - 08/2012
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 08/2012
7	Adenocarcinoma of Lung 03/2022 - 02/2014
5	Lung Neoplasms (Lung Cancer) 03/2024 - 08/2012
3	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 03/2022
2	Carcinogenesis 01/2023 - 03/2014
2	Pleural Effusion (Pleural Effusions) 03/2022 - 03/2019
1	Retinoblastoma (Glioblastoma, Retinal) 01/2024
1	Sarcoma (Soft Tissue Sarcoma) 01/2024
1	Microsatellite Instability 01/2023
1	Disease Progression 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	COVID-19 10/2022
1	Mucositis 03/2022
1	Neutropenia 03/2022
1	Vomiting 03/2022
1	Diarrhea 03/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Pain (Aches) 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Necrosis 12/2020
1	Ischemia 12/2020
1	Hepatitis 01/2020
1	Radiation Injuries (Radiation Sickness) 07/2019
1	Venous Thromboembolism 07/2019
1	Hypoalbuminemia 07/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2019

Drug/Important Bio-Agent (IBA)

9	ErbB Receptors (EGF Receptor)IBA 11/2023 - 02/2014
6	Tyrosine Kinase InhibitorsIBA 01/2024 - 02/2014
5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2012
3	Biomarkers (Surrogate Marker)IBA 06/2018 - 08/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 03/2022
2	apatinibIBA 01/2024 - 10/2017
2	Anaplastic Lymphoma KinaseIBA 03/2019 - 03/2014
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2024
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2024
1	Topoisomerase InhibitorsIBA 01/2024
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2024
1	Epirubicin (Ellence)FDA LinkGeneric 01/2024
1	Antineoplastic Agents (Antineoplastics)IBA 01/2024
1	dalpiciclibIBA 01/2024
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2024
1	Cyclin-Dependent Kinase 4IBA 01/2024
1	Cyclin DIBA 01/2024
1	CholesterolIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Simvastatin (Zocor)FDA LinkGeneric 12/2020
1	B7-H1 AntigenIBA 01/2020
1	Methylprednisolone FDA LinkGeneric 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	pembrolizumabIBA 01/2020
1	bicyclolIBA 01/2020
1	fibrin fragment D (D-dimer)IBA 07/2019
1	AlbuminsIBA 07/2019
1	Serum AlbuminIBA 07/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2019
1	Indicators and Reagents (Reagents)IBA 06/2018
1	Epithelial Cell Adhesion MoleculeIBA 09/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2015
1	nimotuzumabIBA 02/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2015
1	taxaneIBA 02/2015
1	Gemcitabine FDA Link 02/2015
1	Monoclonal AntibodiesIBA 02/2015
1	Immunoglobulin G (IgG)IBA 02/2015
1	Pemetrexed (MTA)FDA Link 02/2015
1	PlatinumIBA 10/2012
1	EndostatinsIBA 08/2012

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 03/2024 - 10/2012
5	Therapeutics 01/2024 - 10/2017
3	Immunotherapy 01/2024 - 01/2020
2	Radiotherapy 12/2021 - 01/2013
1	Exercise Therapy (Therapy, Exercise) 03/2024
1	Hand Hygiene 10/2022
1	Treatment Delay 10/2022